期刊
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
卷 154, 期 -, 页码 -出版社
ELSEVIER
DOI: 10.1016/j.ejps.2020.105510
关键词
Peptidomimetics; OGT; Inhibitors; Molecular dynamics; O-GlcNAc; Glycosylation; Post-translational modification; Molecular docking; Molecular modeling
资金
- Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior-Brazil (CAPES)
- National Council for Scientific and Technological Development (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq)
- Carlos Chagas Filho Foundation for Support of Research of the State of Rio de Janeiro (Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro - FAPERJ)
- Cancer Foundation (Fundacao do Cancer)
The vital enzyme O-linked beta-N-acetylglucosamine transferase (OGT) catalyzes the O-GlcNAcylation of intracellular proteins coupling the metabolic status to cellular signaling and transcription pathways. Aberrant levels of O-GlcNAc and OGT have been linked to metabolic diseases as cancer and diabetes. Here, a new series of peptidomimetic OGT inhibitors was identified highlighting the compound LQMed 330, which presented better IC50 compared to the most potent inhibitors found in the literature. Molecular modeling study of selected inhibitors into the OGT binding site provided insight into the behavior by which these compounds interact with the enzyme. The results obtained in this study provided new perspectives on the design and synthesis of highly specific OGT inhibitors.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据